| Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions (NCT05474794) | Instituto Ecuatoriano de Enfermedades Digestivas | 2022-07-20 |
| Hemostatic Effect of Intrauterine Instillation of Oxytocin in Hysteroscopic Myomectomy (NCT04996498) | Ain Shams Maternity Hospital | 2021-04-15 |
| Dexamethasone for Post Uterine Artery Embolization Pain (NCT04655144) | University of Miami | 2021-01-25 |
| Vitamin D Deficit in Women With Uterine Fibroids (NCT04030182) | Instituto Mexicano del Seguro Social | 2019-12-01 |
| Mechanistic Characterization of Uterine Pain (NCT04145518) | Endeavor Health | 2019-10-25 |
| The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures (NCT04172272) | General Hospital Pula | 2019-09-24 |
| Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas (NCT04214457) | Igenomix | 2019-09-20 |
| Effects of Simvastatin on Uterine Leiomyoma Size (NCT03400826) | Johns Hopkins University | 2018-08-20 |
| Comparison of Pain of Two Different Methods in Uterine Artery Embolization (NCT03420248) | Severance Hospital | 2018-04-19 |
| Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned (NCT03342859) | Bayer | 2017-11-16 |
| Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas (NCT03323905) | Sunnybrook Health Sciences Centre | 2017-11-16 |
| Combined Vaginal Misoprostol and Perivascular Vasopressin (NCT03815344) | Antonios Likourezos | 2017-04-26 |
| Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) (NCT03092999) | Bayer | 2017-03-28 |
| Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) (NCT02889848) | Advance Biofactures Corporation | 2016-10-27 |
| Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy (NCT02777203) | Wake Forest University Health Sciences | 2016-05-01 |
| Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids (NCT02577055) | Assistance Publique - Hôpitaux de Paris | 2016-04-01 |
| New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma (NCT02997787) | Kayseri Education and Research Hospital | 2016-01-01 |
| A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids (NCT02580578) | Allergan | 2015-07-31 |
| Pilot of Letrozole for Uterine Myomas (NCT02470741) | University of California, San Francisco | 2015-07-01 |
| Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids (NCT02465814) | Bayer | 2015-06-01 |
| Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization (NCT02270255) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2015-04-01 |
| Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap (NCT02131662) | Bayer | 2014-05-15 |
| Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids (NCT02189083) | The University of Hong Kong | 2014-05-01 |
| A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas (NCT02147197) | Allergan | 2014-03-31 |
| A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas (NCT02147158) | Allergan | 2014-01-29 |
| Impact of Misoprostol on Blood Loss In Myomectomy Operations (NCT02061657) | Ain Shams University | 2013-06-01 |
| Vascular Function and Uterine Fibroids (NCT02123069) | Mayo Clinic | 2013-04-01 |
| Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation (NCT01998854) | Gynesonics | 2013-02-01 |
| Surgical Success After Laparoscopic vs Abdominal Hysterectomy (NCT01793584) | University of Texas Southwestern Medical Center | 2013-02-01 |
| Fibroid Ablation Study - Large Fibroids (NCT01539187) | Gynesonics | 2012-06-01 |
| Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution (NCT01581905) | Milton S. Hershey Medical Center | 2012-03-01 |
| ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors (NCT01768104) | Nanfang Hospital, Southern Medical University | 2011-12-01 |
| Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 (NCT01816815) | Bayer | 2011-11-01 |
| Fibroid Ablation Study (NCT01226290) | Gynesonics | 2011-01-01 |
| Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids (NCT01311869) | Meharry Medical College | 2010-12-01 |
| Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata (NCT01123603) | The Cleveland Clinic | 2010-05-01 |
| Uterine Artery Embolization and Pelvic Floor Symptoms (NCT00827645) | University of Texas Southwestern Medical Center | 2009-01-01 |
| Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids (NCT00746031) | University of Edinburgh | 2008-12-01 |
| Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study (NCT00768742) | Gynesonics | 2008-09-01 |
| Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata (NCT00731341) | Boston Scientific Corporation | 2008-07-01 |
| Establishment of Fibroid Tissue Bank (NCT00710346) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2008-06-30 |
| Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma (NCT00821275) | Sun Yat-sen University | 2008-01-01 |
| Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy (NCT01530802) | Charite University, Berlin, Germany | 2007-01-01 |
| Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent (NCT00361036) | Worthington-Kirsch, Robert L., M.D. | 2006-08-01 |
| Tissue Bank of Biological Specimens From Patients With Gynecologic Disease (NCT00299481) | U.S. Army Medical Research and Development Command | 2006-03-01 |
| Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914 (NCT00290251) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2006-02-01 |
| Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids (NCT00131365) | InSightec | 2006-01-01 |
| A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) (NCT00628901) | Boston Scientific Corporation | 2006-01-01 |
| Far Infrared Radiation Treatment for Uterine Fibroids (NCT00574418) | GAAD Medical Research Institute Inc. | 2006-01-01 |
| Questionnaire Study to Assess Quality of Life After Treatment of Fibroids (NCT00390494) | U.S. Army Medical Research and Development Command | 2005-12-01 |
| Health-Related QoL Among Women Receiving Hysterectomy in NTUH (NCT00155870) | National Taiwan University Hospital | 2005-06-01 |
| A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas (NCT00219778) | Poitiers University Hospital | 2004-12-01 |
| Study of Asoprisnil in the Treatment of Uterine Fibroids. (NCT00156156) | Abbott | 2004-11-01 |
| Safety of Treatment of Uterine Fibroids With Asoprisnil (NCT00156208) | Abbott | 2004-04-01 |
| A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids (NCT00152256) | Abbott | 2003-09-01 |
| Trial of Mifepristone for Fibroids (NCT00133705) | University of Rochester | 2003-07-01 |
| A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy (NCT00150644) | Abbott | 2003-07-01 |
| Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist (NCT00044876) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-09-02 |
| A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids (NCT00160381) | Abbott | 2002-09-01 |
| Treatment of Uterine Fibroids With Asoprisnil(J867) (NCT00152269) | Abbott | 2002-07-01 |
| Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids (NCT00100191) | ZonMw: The Netherlands Organisation for Health Research and Development | 2002-02-01 |
| A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. (NCT00156182) | Abbott | 2001-04-01 |
| A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids (NCT00160459) | Abbott | 2000-05-01 |
| Evaluation of Women With Endocrine and Reproductive-Related Conditions (NCT00001850) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1999-05-10 |